Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

430 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial.
Klingenberg R, Stähli BE, Heg D, Denegri A, Manka R, Kapos I, von Eckardstein A, Carballo D, Hamm CW, Vietheer J, Rolf A, Landmesser U, Mach F, Moccetti T, Jung C, Kelm M, Münzel T, Pedrazzini G, Räber L, Windecker S, Matter CM, Ruschitzka F, Lüscher TF. Klingenberg R, et al. Among authors: raber l. Am Heart J. 2022 May;247:33-41. doi: 10.1016/j.ahj.2022.01.010. Epub 2022 Jan 28. Am Heart J. 2022. PMID: 35092722 Clinical Trial.
Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.
Windecker S, Remondino A, Eberli FR, Jüni P, Räber L, Wenaweser P, Togni M, Billinger M, Tüller D, Seiler C, Roffi M, Corti R, Sütsch G, Maier W, Lüscher T, Hess OM, Egger M, Meier B. Windecker S, et al. Among authors: raber l. N Engl J Med. 2005 Aug 18;353(7):653-62. doi: 10.1056/NEJMoa051175. Epub 2005 Aug 16. N Engl J Med. 2005. PMID: 16105989 Free article. Clinical Trial.
The DESIRE-Late registry: what is left to be desired?
Windecker S, Räber L. Windecker S, et al. Among authors: raber l. JACC Cardiovasc Interv. 2010 Jan;3(1):19-21. doi: 10.1016/j.jcin.2009.11.008. JACC Cardiovasc Interv. 2010. PMID: 20129563 Free article. No abstract available.
Current status of drug-eluting stents.
Räber L, Windecker S. Räber L, et al. Cardiovasc Ther. 2011 Jun;29(3):176-89. doi: 10.1111/j.1755-5922.2010.00144.x. Epub 2010 Mar 29. Cardiovasc Ther. 2011. PMID: 20370793 Free article. Review.
Sirolimus versus paclitaxel coronary stents in clinical practice.
Millauer N, Jüni P, Hofmann A, Wandel S, Bhambhani A, Billinger M, Urwyler N, Wenaweser P, Hellige G, Räber L, Cook S, Vogel R, Togni M, Seiler C, Meier B, Windecker S. Millauer N, et al. Among authors: raber l. Catheter Cardiovasc Interv. 2011 Jan 1;77(1):5-12. doi: 10.1002/ccd.22597. Catheter Cardiovasc Interv. 2011. PMID: 20506333
Impact of arterial injury on neointimal hyperplasia after implantation of drug-eluting stents in coronary arteries: an intravascular ultrasound study.
Eshtehardi P, Cook S, Wandel S, Räber L, Wenaweser P, Togni M, Vogel R, Garachemani A, Eberli FR, Lüscher TF, Jüni P, Hess OM, Meier B, Windecker S. Eshtehardi P, et al. Among authors: raber l. EuroIntervention. 2010 Sep;6(4):467-74. doi: 10.4244/EIJ30V6I4A79. EuroIntervention. 2010. PMID: 20884434 Free article.
430 results